|
PI4K2B expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.202200E-03 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.703300E-03 |
| Normal-vs-Stage2 |
1.766450E-01 |
| Normal-vs-Stage3 |
1.261470E-03 |
| Normal-vs-Stage4 |
3.828900E-04 |
| Stage1-vs-Stage2 |
7.832200E-01 |
| Stage1-vs-Stage3 |
1.368430E-01 |
| Stage1-vs-Stage4 |
1.776780E-01 |
| Stage2-vs-Stage3 |
2.518800E-01 |
| Stage2-vs-Stage4 |
3.444200E-01 |
| Stage3-vs-Stage4 |
7.993800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.738800E-03 |
| Normal-vs-AfricanAmerican |
7.80299999947331E-07 |
| Normal-vs-Asian |
4.391000E-01 |
| Caucasian-vs-AfricanAmerican |
1.498000E-03 |
| Caucasian-vs-Asian |
7.906400E-01 |
| AfricanAmerican-vs-Asian |
3.050000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.379530E-03 |
| Normal-vs-Female |
5.895300E-03 |
| Male-vs-Female |
7.583400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.956300E-04 |
| Normal-vs-Age(41-60Yrs) |
3.703000E-03 |
| Normal-vs-Age(61-80Yrs) |
2.563400E-03 |
| Normal-vs-Age(81-100Yrs) |
8.612200E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.134200E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.105800E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.457380E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.244400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.880000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.363400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.909000E-01 |
| Normal-vs-Grade 2 |
4.351800E-02 |
| Normal-vs-Grade 3 |
1.387720E-04 |
| Normal-vs-Grade 4 |
5.98130000000197E-05 |
| Grade 1-vs-Grade 2 |
9.343600E-01 |
| Grade 1-vs-Grade 3 |
2.952400E-01 |
| Grade 1-vs-Grade 4 |
1.667770E-01 |
| Grade 2-vs-Grade 3 |
7.238400E-02 |
| Grade 2-vs-Grade 4 |
2.233800E-02 |
| Grade 3-vs-Grade 4 |
2.618800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.420800E-01 |
| Normal-vs-ccB subtype |
2.397100E-04 |
| ccA subtype-vs-ccB subtype |
1.981570E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.375900E-03 |
| Normal-vs-N1 |
4.065800E-02 |
| N0-vs-N1 |
7.300200E-01 |
|
|
